NEW YORK STATE COMMON RETIREMENT FUND - Y-MABS THERAPEUTICS INC ownership

Y-MABS THERAPEUTICS INC's ticker is YMAB and the CUSIP is 984241109. A total of 100 filers reported holding Y-MABS THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
NEW YORK STATE COMMON RETIREMENT FUND ownership history of Y-MABS THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$34
-19.0%
6,270
+1.6%
0.00%
Q2 2023$42
+35.5%
6,173
-0.8%
0.00%
Q1 2023$31
-74.2%
6,225
-74.7%
0.00%
Q4 2022$120
-100.0%
24,625
+0.0%
0.00%
-100.0%
Q3 2022$355,000
-4.6%
24,615
+0.2%
0.00%
Q2 2022$372,000
+27.4%
24,554
-0.1%
0.00%
Q1 2022$292,000
-92.4%
24,579
-89.6%
0.00%
-100.0%
Q4 2021$3,830,000
-55.6%
236,284
-21.8%
0.00%
-55.6%
Q3 2021$8,619,000
+5.5%
301,998
+24.9%
0.01%
+12.5%
Q2 2021$8,172,000
+13.3%
241,770
+1.4%
0.01%0.0%
Q1 2021$7,213,000
-27.0%
238,527
+19.5%
0.01%
-27.3%
Q4 2020$9,882,000
+71.6%
199,599
+33.1%
0.01%
+57.1%
Q3 2020$5,758,000
+5.1%
149,980
+18.3%
0.01%0.0%
Q2 2020$5,477,000
+74.8%
126,778
+5.6%
0.01%
+40.0%
Q1 2020$3,134,000
+382.2%
120,078
+477.3%
0.01%
+400.0%
Q4 2019$650,000
+19.9%
20,8000.0%0.00%0.0%
Q3 2019$542,000
+13.9%
20,8000.0%0.00%0.0%
Q2 2019$476,000
+655.6%
20,800
+766.7%
0.00%
Q1 2019$63,0002,4000.00%
Other shareholders
Y-MABS THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Memorial Sloan Kettering Cancer Center 191,176$1,041,9094.24%
Sofinnova Investments, Inc. 2,194,278$11,958,8150.75%
DENALI ADVISORS LLC 85,900$468,1550.16%
Polar Capital Holdings Plc 2,103,298$11,462,9740.08%
Soleus Capital Management, L.P. 157,182$856,6420.08%
GSA CAPITAL PARTNERS LLP 137,299$7480.06%
Caligan Partners LP 23,321$127,0990.06%
Corton Capital Inc. 12,244$66,7300.03%
RICE HALL JAMES & ASSOCIATES, LLC 91,249$497,3070.03%
CIM INVESTMENT MANAGEMENT INC 15,313$83,4560.03%
View complete list of Y-MABS THERAPEUTICS INC shareholders